Temasek, Taikang lead $60m Series C2 round for Chinese speech therapy firm OST
The new financing is the second tranche of OST's $83-million Series C round.
Stay updated with breaking news from Orient Speech Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The new financing is the second tranche of OST's $83-million Series C round.
China’s Long Hill Capital closes third USD fund at over $300m April 6, 2021 Healthcare-focused Chinese venture capital firm Long Hill Capital on Tuesday announced that it has secured over $300 million for its third USD-denominated fund. The vehicle will primarily make early-stage investments in healthcare and longevity companies, along with select growth-stage bets. The fundraising takes the Chinese VC’s total committed capital to about 6 billion yuan ($800 million), it said in a statement. Long Hill Capital had closed its second USD fund at $265 million in 2018. The latest fund, which is...
China Digest: Orient Speech Therapy bags $23m; Lightspeed invests in PrecisioNext Premium Orient Speech Therapy (OST) has pocketed $23 million in its Series C1 round of financing led by Cenova Capital, while PrecisioNext has closed its Series B round raising 100 million yuan ($15 million). Continue reading this story with a subscription to DealStreetAsia. Contact us for corporate subscriptions at subs@dealstreetasia.com. Sign up for our newsletter - The Daily Brief Opt out of receiving The Daily Brief in your inbox everyday REGISTER stories_left_pl...